The DOI matches its Crossref record.
Association of interleukin‐23 receptor variants with ankylosing spondylitis
Abstract
Objective: Recent studies have shown that a nonsynonymous single‐nucleotide polymorphism (SNP) (Arg381Gln; rs11209026) in the interleukin‐23 receptor (IL‐23R) gene on chromosome 1p31 is associated with Crohn's disease and psoriasis. Given the clinical and immunologic overlap between ankylosing spondylitis (AS) and these diseases, and the potential function of this candidate SNP, this study was undertaken to examine the association of IL‐23R variants with AS in multiple Canadian populations. Methods: We examined 3 cohorts of AS patients from established rheumatic disease centers in Canada. The majority of AS patients were Caucasians of northern European descent, and all patients satisfied the modified New York classification criteria for AS or for juvenile spondylarthritis. We examined 424 AS probands and 401 controls from Alberta, 251 AS probands and 122 controls from Toronto, and 121 AS probands and 219 controls from Newfoundland. Ten IL‐23R SNPs were genotyped, 9 of which were incorporated in the haplotype analysis. Allele and haplotype associations were calculated using the WHAP software package.P values for haplotype associations were calculated using a permutation test. Results: The primary SNP of interest in a previous study of inflammatory bowel disease (IBD) (Arg381Gln; rs11209026) was found to be protective against AS in the Newfoundland population (P= 0.04) and in the Toronto population (P= 0.04) in single‐marker univariate analysis. The strongest association, however, was with SNP rs11465804 (P= 0.007 for the Newfoundland population and P= 0.0007 for the Toronto population). A 3‐marker sliding window omnibus test revealed a significant association with markers rs10489629, rs2201841, and rs11465804 in both the Newfoundland population (P= 0.04) and the Alberta population (P= 0.034). Our results were independent of the IBD and psoriasis status of the AS patients. Conclusion: This concurrent analysis of 3 distinct AS populations and their regional controls demonstrates a disease association with the IL‐23R locus and implicates the same polymorphisms associated with IBD and psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Induction and molecular signature of pathogenic TH17 cells
Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2416 · Cited by 1,174
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
Sherlock, J. P., Joyce-Shaikh, B., Turner, S. P., Chao, C.-C., Sathe, M., Grein, J., Gorman, D. M., Bowman, E. P., McClanahan, T. K., Yearley, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2817 · Cited by 1,060
Shen, H., Goodall, J. C., & Hill Gaston, J. S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24568 · Cited by 516
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
Patel, D. D., & Kuchroo, V. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.12.003 · Cited by 486
Metadata
- Authors
- Rahman, P., Inman, R. D., Gladman, D. D., Reeve, J. P., Peddle, L., & Maksymowych, W. P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2008-03-27
- Volume
- 58
- Issue
- 4
- Pages
- 1020-1025
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2084359725
- Cited by
- 181
- References
- 0
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of interleukin‐23 receptor variants with ankylosing spondylitis. https://app.cochat.ai/papers/10.1002/art.23389
- The paper
- Rahman, P., Inman, R. D., Gladman, D. D., Reeve, J. P., Peddle, L., & Maksymowych, W. P. (2008). Association of interleukin‐23 receptor variants with ankylosing spondylitis. Arthritis & Rheumatism. https://doi.org/10.1002/art.23389
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.